Care of the immunocompromised cancer patient in the perioperative period: Narrative review

Keyphrases

• Cancer Patients 100%
• Surgical Procedures 100%
• Perioperative Period 100%
• Narrative Review 100%
• Cancer Outcomes 50%
• Patients with Cancer 50%
• Neutropenia 50%
• Cancer Control 50%
• Lymphopenia 50%
• Overall Survival Rate 50%
• Cancer Incidence 50%
• Corticosteroids 50%
• Non-cancer 50%
• Immunocompromised Patients 50%
• Cytotoxic Drugs 50%
• Perioperative Care 50%
• Over 80 50%
• Severe Infection 50%
• Immune-compromised 50%
• Anesthesia Care 50%
• Immunological Profile 50%
• Over 45 50%
• Immune Impairment 50%
• Cancer-associated 50%
• Postprocedural Care 50%
• Patient Will 50%
• Enhanced Risks 50%
• Prognosis Survival 50%
• Unique Needs 50%
• Global Public Health Concern 50%

Nursing and Health Professions

• Malignant Neoplasm 100%
• Perioperative Period 100%
• Surgical Technique 40%
• Infection 20%
• Survival Rate 20%
• Overall Survival 20%
• Neutropenia 20%
• Immunotherapy 20%
• Immunocompromised Patient 20%
• Perioperative 20%
• Cancer Control 20%
• Cytotoxic Agent 20%
• Lymphocytopenia 20%
• Corticosteroid 20%
• Public Health 20%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Perioperative Period 100%
• Surgical Technique 40%
• Infection 20%
• Overall Survival 20%
• Public Health 20%
• Immunotherapy 20%
• Cancer Control 20%
• Lymphocytopenia 20%
• Survival Rate 20%
• Neutropenia 20%
• Cytotoxic Agent 20%
• Immunocompromised Patient 20%
• Corticosteroid 20%